Mr. Didier Leconte is a collaborative leader with a passion for Life Sciences and innovation. He excels at linking technology, business and investments to drive growth and create value thru strategic thinking. He has extensive Board experience. Mr. Leconte is currently Director, Epitopea; Director, Morphocell Technologies; Director, DalCor Pharma; Director, Congruence Tx. He is the past Chair of adMare Bioinnovations.  He hold an MBA in Technology and Innovation Management, a Governance certification from Université Laval, and an Engineering Degree, Material Sciences.